Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathaniel Katz

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
The Clinical Journal of Pain|June 25, 2008
Internet-based survey of nonmedical prescription opioid use in the United StatesNathaniel Katz, Kathrine Fernandez, Alan Chang, et al.
Journal of Pain Research|December 11, 2019
Number Of Clinical Trial Study Sites Impacts Observed Treatment Effect Size: An Analysis Of Randomized Controlled Trials Of Opioids For Chronic PainDiana S Meske, Ben J Vaughn, Ernest A Kopecky, et al.
Transfusion|October 29, 2008
Ultrasound-enabled topical anesthesia for pain reduction of phlebotomy for whole blood donationChristopher P Stowell, My-Quyen Trieu, Han Chuang, et al.
Therapeutic Advances in Drug Safety|October 27, 2018
Medication errors involving intravenous patient-controlled analgesia: results from the 2005-2015 MEDMARX databaseMaitreyee Mohanty, Oluwadolapo D Lawal, Margie Skeer, et al.
Pain|August 12, 2015
A phase 3, multicenter, randomized, double-blind, placebo-controlled, safety, tolerability, and efficacy study of Xtampza ER in patients with moderate-to-severe chronic low back painNathaniel Katz, Ernest A Kopecky, Melinda O'Connor, et al.
The American Journal of Drug and Alcohol Abuse|April 27, 2011
Tampering with prescription opioids: nature and extent of the problem, health consequences, and solutionsNathaniel Katz, Richard C Dart, Elise Bailey, et al.
Pain|July 20, 2016
Efficacy and tolerability of buccal buprenorphine in opioid-experienced patients with moderate to severe chronic low back pain: results of a phase 3, enriched enrollment, randomized withdrawal studyJoseph Gimbel, Egilius L H Spierings, Nathaniel Katz, et al.
Journal of Pain Research|May 17, 2018
Efficacy of opioids versus placebo in chronic pain: a systematic review and meta-analysis of enriched enrollment randomized withdrawal trialsDiana S Meske, Oluwadolapo D Lawal, Harrison Elder, et al.
The Journal of Rheumatology|November 3, 2010
Further qualification of a therapeutic responder index for patients with chronic low back painClaire Bombardier, Chris J Evans, Nathaniel Katz, et al.
Expert Opinion on Drug Safety|February 22, 2018
The nature, magnitude, and reporting compliance of device-related events for intravenous patient-controlled analgesia in the FDA Manufacturer and User Facility Device Experience (MAUDE) databaseOluwadolapo D Lawal, Maitreyee Mohanty, Harrison Elder, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
The Clinical Journal of Pain|June 25, 2008
Internet-based survey of nonmedical prescription opioid use in the United StatesNathaniel Katz, Kathrine Fernandez, Alan Chang, et al.
Journal of Pain Research|December 11, 2019
Number Of Clinical Trial Study Sites Impacts Observed Treatment Effect Size: An Analysis Of Randomized Controlled Trials Of Opioids For Chronic PainDiana S Meske, Ben J Vaughn, Ernest A Kopecky, et al.
Transfusion|October 29, 2008
Ultrasound-enabled topical anesthesia for pain reduction of phlebotomy for whole blood donationChristopher P Stowell, My-Quyen Trieu, Han Chuang, et al.
Therapeutic Advances in Drug Safety|October 27, 2018
Medication errors involving intravenous patient-controlled analgesia: results from the 2005-2015 MEDMARX databaseMaitreyee Mohanty, Oluwadolapo D Lawal, Margie Skeer, et al.
Pain|August 12, 2015
A phase 3, multicenter, randomized, double-blind, placebo-controlled, safety, tolerability, and efficacy study of Xtampza ER in patients with moderate-to-severe chronic low back painNathaniel Katz, Ernest A Kopecky, Melinda O'Connor, et al.
The American Journal of Drug and Alcohol Abuse|April 27, 2011
Tampering with prescription opioids: nature and extent of the problem, health consequences, and solutionsNathaniel Katz, Richard C Dart, Elise Bailey, et al.
Pain|July 20, 2016
Efficacy and tolerability of buccal buprenorphine in opioid-experienced patients with moderate to severe chronic low back pain: results of a phase 3, enriched enrollment, randomized withdrawal studyJoseph Gimbel, Egilius L H Spierings, Nathaniel Katz, et al.
Journal of Pain Research|May 17, 2018
Efficacy of opioids versus placebo in chronic pain: a systematic review and meta-analysis of enriched enrollment randomized withdrawal trialsDiana S Meske, Oluwadolapo D Lawal, Harrison Elder, et al.
The Journal of Rheumatology|November 3, 2010
Further qualification of a therapeutic responder index for patients with chronic low back painClaire Bombardier, Chris J Evans, Nathaniel Katz, et al.
Expert Opinion on Drug Safety|February 22, 2018
The nature, magnitude, and reporting compliance of device-related events for intravenous patient-controlled analgesia in the FDA Manufacturer and User Facility Device Experience (MAUDE) databaseOluwadolapo D Lawal, Maitreyee Mohanty, Harrison Elder, et al.
Pageof 7